Molecular mechanism of C-reaction protein in promoting migration and invasion of hepatocellular carcinoma cells in vitro

Shen,Shasha; Gong,Jiaojiao; Yang,Yixuan; Qin,Si; Huang,Lifan; She,Sha; Yang,Min; Ren,Hong; Hu,Huaidong

doi:10.3892/ijo.2017.3911

Molecular mechanism of C-reaction protein in promoting migration and invasion of hepatocellular carcinoma cells in vitro

Authors:
- Shasha Shen
- Jiaojiao Gong
- Yixuan Yang
- Si Qin
- Lifan Huang
- Sha She
- Min Yang
- Hong Ren
- Huaidong Hu
View Affiliations

Affiliations: Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, P.R. China
Published online on: March 13, 2017 https://doi.org/10.3892/ijo.2017.3911
Pages: 1289-1298

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hepatocellular carcinoma (HCC) is one of most common malignant cancers and is the second leading cause of cancer related deaths. The prognosis and survival of patients are closely related to the degree of tumor metastasis. The mechanism of HCC metastasis is still unclear. In the present study, we investigated the molecular mechanism of C-reaction protein in promoting migration and invasion of hepatocellular carcinoma cells in vitro. We estimated that CRP is overexpressed in liver cancer tissues and that it promotes invasion and metastasis of HCC in vitro. In the present study, we employed iTRAQ-based mass spectrometry to analyze the HepG2 secretory proteins of CRP siRNA-treated cells and negative control siRNA-treated cells. We identified 109 differentially expressed proteins after silencing CRP, of which 45 were upregulated and 64 were downregulated. Some of the differentially expressed proteins were confirmed by western blot analysis and real-time quantitative PCR. Furthermore, we found that knockdown of CRP substantially abrogates HIF-1α expression levels, the luciferase activity of HIF-1α and ERK and Akt phosphorylation in HepG2 cells. The present study provides a novel mechanism by which CRP promotes the proliferation, migration, invasion and metastasis of hepatocellular carcinoma cells. Inhibition of CRP suppressed migration, invasion and healing of hepatoma carcinoma cells by decreasing HIF-1α activity and CTSD.

View Figures

View References

1	El-Serag HB: Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 142:1264–1273.e1. 2012. View Article : Google Scholar : PubMed/NCBI
2	El-Serag HB and Kanwal F: Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go? Hepatology. 60:1767–1775. 2014. View Article : Google Scholar : PubMed/NCBI
3	Ren W, Qi X, Jia J, Yang M and Han G: Hepatocellular carcinoma. Lancet (London, England). 380:469author reply 470–461. 2012. View Article : Google Scholar
4	Stein MP, Edberg JC, Kimberly RP, Mangan EK, Bharadwaj D, Mold C and Du Clos TW: C-reactive protein binding to FcgammaRIIa on human monocytes and neutrophils is allele-specific. J Clin Invest. 105:369–376. 2000. View Article : Google Scholar : PubMed/NCBI
5	Pepys MB: C-reactive protein: The role of an ancient protein in modern rheumatology. Clin Exp Rheumatol. 1:3–7. 1983.PubMed/NCBI
6	Hefler LA, Concin N, Hofstetter G, Marth C, Mustea A, Sehouli J, Zeillinger R, Leipold H, Lass H, Grimm C, et al: Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer. Clin Cancer Res. 14:710–714. 2008. View Article : Google Scholar : PubMed/NCBI
7	Xu M, Zhu M, Du Y, Yan B, Wang Q, Wang C and Zhao J: Serum C-reactive protein and risk of lung cancer: A case-control study. Med Oncol. 30:3192013. View Article : Google Scholar
8	Chung YC and Chang YF: Serum C-reactive protein correlates with survival in colorectal cancer patients but is not an independent prognostic indicator. Eur J Gastroenterol Hepatol. 15:369–373. 2003. View Article : Google Scholar : PubMed/NCBI
9	Bataille R, Boccadoro M, Klein B, Durie B and Pileri A: C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system. Blood. 80:733–737. 1992.PubMed/NCBI
10	Legouffe E, Rodriguez C, Picot MC, Richard B, Klein B, Rossi JF and Commes T: C-reactive protein serum level is a valuable and simple prognostic marker in non Hodgkin's lymphoma. Leuk Lymphoma. 31:351–357. 1998. View Article : Google Scholar : PubMed/NCBI
11	Yang J, Wezeman M, Zhang X, Lin P, Wang M, Qian J, Wan B, Kwak LW, Yu L and Yi Q: Human C-reactive protein binds activating Fcgamma receptors and protects myeloma tumor cells from apoptosis. Cancer Cell. 12:252–265. 2007. View Article : Google Scholar : PubMed/NCBI
12	Liu F, Chen HY, Huang XR, Chung AC, Zhou L, Fu P, Szalai AJ and Lan HY: C-reactive protein promotes diabetic kidney disease in a mouse model of type 1 diabetes. Diabetologia. 54:2713–2723. 2011. View Article : Google Scholar : PubMed/NCBI
13	Ho J, Kong JW, Choong LY, Loh MC, Toy W, Chong PK, Wong CH, Wong CY, Shah N and Lim YP: Novel breast cancer metastasis-associated proteins. J Proteome Res. 8:583–594. 2009. View Article : Google Scholar
14	Hu H, Ding X, Yang Y, Zhang H, Li H, Tong S, An X, Zhong Q, Liu X, Ma L, et al: Changes in glucose-6-phosphate dehydrogenase expression results in altered behavior of HBV-associated liver cancer cells. Am J Physiol Gastrointest Liver Physiol. 307:G611–G622. 2014. View Article : Google Scholar : PubMed/NCBI
15	Ran X, Xu X, Yang Y, She S, Yang M, Li S, Peng H, Ding X, Hu H, Hu P, et al: A quantitative proteomics study on olfactomedin 4 in the development of gastric cancer. Int J Oncol. 47:1932–1944. 2015.PubMed/NCBI
16	Wang LN, Tong SW, Hu HD, Ye F, Li SL, Ren H, Zhang DZ, Xiang R and Yang YX: Quantitative proteome analysis of ovarian cancer tissues using a iTRAQ approach. J Cell Biochem. 113:3762–3772. 2012. View Article : Google Scholar : PubMed/NCBI
17	Yang Y, Toy W, Choong LY, Hou P, Ashktorab H, Smoot DT, Yeoh KG and Lim YP: Discovery of SLC3A2 cell membrane protein as a potential gastric cancer biomarker: Implications in molecular imaging. J Proteome Res. 11:5736–5747. 2012.PubMed/NCBI
18	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
19	Gan CS, Chong PK, Pham TK and Wright PC: Technical, experimental, and biological variations in isobaric tags for relative and absolute quantitation (iTRAQ). J Proteome Res. 6:821–827. 2007. View Article : Google Scholar : PubMed/NCBI
20	Zhou C, Simpson KL, Lancashire LJ, Walker MJ, Dawson MJ, Unwin RD, Rembielak A, Price P, West C, Dive C, et al: Statistical considerations of optimal study design for human plasma proteomics and biomarker discovery. J Proteome Res. 11:2103–2113. 2012. View Article : Google Scholar : PubMed/NCBI
21	Krishnamachary B, Berg-Dixon S, Kelly B, Agani F, Feldser D, Ferreira G, Iyer N, LaRusch J, Pak B, Taghavi P, et al: Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res. 63:1138–1143. 2003.PubMed/NCBI
22	Dian D, Heublein S, Wiest I, Barthell L, Friese K and Jeschke U: Significance of the tumor protease cathepsin D for the biology of breast cancer. Histol Histopathol. 29:433–438. 2014.
23	Yoo YA, Kang MH, Lee HJ, Kim BH, Park JK, Kim HK, Kim JS and Oh SC: Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer. Cancer Res. 71:7061–7070. 2011. View Article : Google Scholar : PubMed/NCBI
24	Chen J, Gu Z, Wu M, Yang Y, Zhang J, Ou J, Zuo Z, Wang J and Chen Y: C-reactive protein can upregulate VEGF expression to promote ADSC-induced angiogenesis by activating HIF-1α via CD64/PI3k/Akt and MAPK/ERK signaling pathways. Stem Cell Res Ther. 7:1142016. View Article : Google Scholar
25	Lee IN, Chen CH, Sheu JC, Lee HS, Huang GT, Chen DS, Yu CY, Wen CL, Lu FJ and Chow LP: Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular carcinoma using a proteomics approach. Proteomics. 6:2865–2873. 2006. View Article : Google Scholar : PubMed/NCBI
26	Feng JT, Liu YK, Song HY, Dai Z, Qin LX, Almofti MR, Fang CY, Lu HJ, Yang PY and Tang ZY: Heat-shock protein 27: A potential biomarker for hepatocellular carcinoma identified by serum proteome analysis. Proteomics. 5:4581–4588. 2005. View Article : Google Scholar : PubMed/NCBI
27	She S, Xiang Y, Yang M, Ding X, Liu X, Ma L, Liu Q, Liu B, Lu Z, Li S, et al: C-reactive protein is a biomarker of AFP-negative HBV-related hepatocellular carcinoma. Int J Oncol. 47:543–554. 2015.PubMed/NCBI
28	Westley B and Rochefort H: A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell. 20:353–362. 1980. View Article : Google Scholar : PubMed/NCBI
29	Rochefort H, Capony F, Garcia M, Cavaillès V, Freiss G, Chambon M, Morisset M and Vignon F: Estrogen-induced lysosomal proteases secreted by breast cancer cells: A role in carcinogenesis? J Cell Biochem. 35:17–29. 1987. View Article : Google Scholar : PubMed/NCBI
30	Berchem G, Glondu M, Gleizes M, Brouillet JP, Vignon F, Garcia M and Liaudet-Coopman E: Cathepsin-D affects multiple tumor progression steps in vivo: Proliferation, angiogenesis and apoptosis. Oncogene. 21:5951–5955. 2002. View Article : Google Scholar : PubMed/NCBI
31	Vashishta A, Ohri SS, Proctor M, Fusek M and Vetvicka V: Ribozyme-targeting procathepsin D and its effect on invasion and growth of breast cancer cells: An implication in breast cancer therapy. Int J Oncol. 30:1223–1230. 2007.PubMed/NCBI
32	Glondu M, Liaudet-Coopman E, Derocq D, Platet N, Rochefort H and Garcia M: Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells. Oncogene. 21:5127–5134. 2002. View Article : Google Scholar : PubMed/NCBI
33	Briozzo P, Badet J, Capony F, Pieri I, Montcourrier P, Barritault D and Rochefort H: MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: A permissive role of cathepsin D. Exp Cell Res. 194:252–259. 1991. View Article : Google Scholar : PubMed/NCBI
34	Piwnica D, Fernandez I, Binart N, Touraine P, Kelly PA and Goffin V: A new mechanism for prolactin processing into 16K PRL by secreted cathepsin D. Mol Endocrinol. 20:3263–3278. 2006. View Article : Google Scholar : PubMed/NCBI
35	Keith B, Johnson RS and Simon MC: HIF1α and HIF2α: Sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer. 12:9–22. 2011.PubMed/NCBI
36	Hung JJ, Yang MH, Hsu HS, Hsu WH, Liu JS and Wu KJ: Prognostic significance of hypoxia-inducible factor-1alpha, TWIST1 and Snail expression in resectable non-small cell lung cancer. Thorax. 64:1082–1089. 2009. View Article : Google Scholar : PubMed/NCBI
37	Kim SJ, Rabbani ZN, Dewhirst MW, Vujaskovic Z, Vollmer RT, Schreiber EG, Oosterwijk E and Kelley MJ: Expression of HIF-1alpha, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer. Lung Cancer. 49:325–335. 2005. View Article : Google Scholar : PubMed/NCBI
38	Giatromanolaki A, Koukourakis MI, Sivridis E, Turley H, Talks K, Pezzella F, Gatter KC and Harris AL: Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br J Cancer. 85:881–890. 2001. View Article : Google Scholar : PubMed/NCBI